Cargando…
Allogeneic adipose tissue‐derived stem cells ELIXCYTE(®) in chronic kidney disease: A phase I study assessing safety and clinical feasibility
The purpose of this phase I clinical trial is to assess the safety and tolerability of allogeneic adipose tissue‐derived stem cells (ADSCs) among chronic kidney disease (CKD) patients. 12 eligible CKD patients with an estimated glomerular filtration rate (eGFR) of 15–44 ml/min/1.73 m(2) received one...
Autores principales: | Zheng, Cai‐Mei, Chiu, I‐Jen, Chen, Yu‐Wei, Hsu, Yung‐Ho, Hung, Lie‐Yee, Wu, Mei‐Yi, Lin, Yuh‐Feng, Liao, Chia‐Te, Hung, Yi‐Pei, Tsai, Chia‐Chu, Cherng, Yih‐Giun, Wu, Mai‐Szu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097837/ https://www.ncbi.nlm.nih.gov/pubmed/35415928 http://dx.doi.org/10.1111/jcmm.17310 |
Ejemplares similares
-
Treatment of knee osteoarthritis with intra-articular injection of allogeneic adipose-derived stem cells (ADSCs) ELIXCYTE®: a phase I/II, randomized, active-control, single-blind, multiple-center clinical trial
por: Chen, Cheng-Fong, et al.
Publicado: (2021) -
Severe acute kidney disease is associated with worse kidney outcome among acute kidney injury patients
por: Chen, Yu-Wei, et al.
Publicado: (2022) -
The Influence of Diabetes Mellitus on the Risks of End-Stage Kidney Disease and Mortality After Liver Transplantation
por: Lee, Chung-Ying, et al.
Publicado: (2022) -
Aberrant serum parathyroid hormone, calcium, and phosphorus as risk factors for peritonitis in peritoneal dialysis patients
por: Liao, Chia-Te, et al.
Publicado: (2021) -
Author Correction: Aberrant serum parathyroid hormone, calcium, and phosphorus as risk factors for peritonitis in peritoneal dialysis patients
por: Liao, Chia-Te, et al.
Publicado: (2022)